Peter Lynch · Growth at a reasonable price (GARP)
Is Halozyme Therapeutics, Inc. (HALO) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
62/100
No encaja
3/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a HALO
PEG ≤ 1.0
clave-
EPS CAGR ≥ 15%
clave-2.0%
Revenue CAGR ≥ 10%
33.2%
Net margin > 0
23.1%
Cómo se valora HALO en otras estrategias
Datos financieros en vivo
Cap. mercado
$12.29B
PER (TTM)
23.3x
ROIC (TTM)
23.65%
Margen bruto
76.93%
Otros análisis Peter Lynch
Preguntas frecuentes
What is HALO's Peter Lynch fit score?
HALO scores 62/100 on our Peter Lynch fit engine. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own HALO?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends HALO.
How often is this score updated?
HALO's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende HALO personalmente.
